Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Acute Respiratory Distress Syndrome Market


6. Market Share – Global Acute Respiratory Distress Syndrome

6.1 By Type
6.2 By End User
6.3 By Regions


7. Type - Global Acute Respiratory Distress Syndrome Market

7.1 Diagnosis
7.2 Treatment


8. End-User - Global Acute Respiratory Distress Syndrome Market

8.1 Hospitals
8.2 Specialty clinics
8.3 Home healthcare
8.4 Others


9. Regions - Global Acute Respiratory Distress Syndrome Market

9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 South America
9.5 Middle East and Africa


10. Company Analysis

10.1 Silence Therapeutics plc

10.1.1 Overview
10.1.2 Recent Developments
10.1.3 Financial Insights

10.2 GILEAD SCIENCES INC

10.2.1 Overview
10.2.2 Recent Developments
10.2.3 Financial Insights

10.3 Terumo Corporation

10.3.1 Overview
10.3.2 Recent Developments
10.3.3 Financial Insights

10.4 GETINGE AB

10.4.1 Overview
10.4.2 Recent Developments
10.4.3 Financial Insights

10.5 Medtronic, Inc

10.5.1 Overview
10.5.2 Recent Developments
10.5.3 Financial Insights

10.6 FRESENIUS SE & CO. KGAA

10.6.1 Overview
10.6.2 Recent Developments
10.6.3 Financial Insights

10.7 NIPRO

10.7.1 Overview
10.7.2 Recent Developments
10.7.3 Financial Insights

10.8 PFIZER INC

10.8.1 Overview
10.8.2 Recent Developments
10.8.3 Financial Insights



List of Figures

Figure-01: Global – Acute Respiratory Distress Syndrome Market (Million US$), 2018 – 2022
Figure-02: Global – Forecast for Acute Respiratory Distress Syndrome Market (Million US$), 2023 – 2028
Figure-03: Type – Diagnosis Market (Million US$), 2018 – 2022
Figure-04: Type – Forecast for Diagnosis Market (Million US$), 2023 – 2028
Figure-05: Type – Treatment Market (Million US$), 2018 – 2022
Figure-06: Type – Forecast for Treatment Market (Million US$), 2023 – 2028
Figure-07: End-User – Hospitals Market (Million US$), 2018 – 2022
Figure-08: End-User – Forecast for Hospitals Market (Million US$), 2023 – 2028
Figure-09: End-User – Specialty clinics Market (Million US$), 2018 – 2022
Figure-10: End-User – Forecast for Specialty clinics Market (Million US$), 2023 – 2028
Figure-11: End-User – Home healthcare Market (Million US$), 2018 – 2022
Figure-12: End-User – Forecast for Home healthcare Market (Million US$), 2023 – 2028
Figure-13: End-User – Others Market (Million US$), 2018 – 2022
Figure-14: End-User – Forecast for Others Market (Million US$), 2023 – 2028
Figure-15: North America – Acute Respiratory Distress Syndrome Market (Million US$), 2018 – 2022
Figure-16: North America – Forecast for Acute Respiratory Distress Syndrome Market (Million US$), 2023 – 2028
Figure-17: Europe – Acute Respiratory Distress Syndrome Market (Million US$), 2018 – 2022
Figure-18: Europe – Forecast for Acute Respiratory Distress Syndrome Market (Million US$), 2023 – 2028
Figure-19: Asia Pacific – Acute Respiratory Distress Syndrome Market (Million US$), 2018 – 2022
Figure-20: Asia Pacific – Forecast for Acute Respiratory Distress Syndrome Market (Million US$), 2023 – 2028
Figure-21: South America – Acute Respiratory Distress Syndrome Market (Million US$), 2018 – 2022
Figure-22: South America – Forecast for Acute Respiratory Distress Syndrome Market (Million US$), 2023 – 2028
Figure-23: Middle East and Africa – Acute Respiratory Distress Syndrome Market (Million US$), 2018 – 2022
Figure-24: Middle East and Africa – Forecast for Acute Respiratory Distress Syndrome Market (Million US$), 2023 – 2028
Figure-25: Silence Therapeutics plc – Global Revenue (Million US$), 2019 – 2022
Figure-26: Silence Therapeutics plc – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-27: GILEAD SCIENCES INC – Global Revenue (Billion US$), 2018 – 2022
Figure-28: GILEAD SCIENCES INC – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-29: Terumo Corporation – Global Revenue (Billion US$), 2018 – 2022
Figure-30: Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-31: GETINGE AB – Global Revenue (Billion US$), 2018 – 2022
Figure-32: GETINGE AB – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-33: Medtronic, Inc – Global Revenue (Billion US$), 2018 – 2022
Figure-34: Medtronic, Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-35: FRESENIUS SE & CO. KGAA – Global Revenue (Billion US$), 2018 – 2022
Figure-36: FRESENIUS SE & CO. KGAA – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-37: NIPRO – Global Revenue (Billion US$), 2018 – 2022
Figure-38: NIPRO – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-39: PFIZER INC – Global Revenue (Billion US$), 2018 – 2022
Figure-40: PFIZER INC – Forecast for Global Revenue (Billion US$), 2023 – 2028

List of Tables

Table-01: Global – Acute Respiratory Distress Syndrome Market Share by Type (Percent), 2018 – 2022
Table-02: Global – Forecast for Acute Respiratory Distress Syndrome Market Share by Type (Percent), 2023 – 2028
Table-03: Global – Acute Respiratory Distress Syndrome Market Share by End User (Percent), 2018 – 2022
Table-04: Global – Forecast for Acute Respiratory Distress Syndrome Market Share by End User (Percent), 2023 – 2028
Table-05: Global – Acute Respiratory Distress Syndrome Market Share by Regions (Percent), 2018 – 2022
Table-06: Global – Forecast for Acute Respiratory Distress Syndrome Market Share by Regions (Percent), 2023 – 2028